Cancer stem cell surface markers on normal stem cells

키워드

참고문헌 (166)

1. Visvader JE, "Cancer stem cells in solid tumours: accumulating evidence and unresolved questions", Nat Rev Cancer, 8, pp.755~768 (2008)
2. Tirino V, "Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization", FASEB J, 27, pp.13~24 (2013)
3. Bonnet D, "Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell", Nat Med, 3, pp.730~737 (1997)
4. Al-Hajj M, "Prospective identification of tumorigenic breast cancer cells", Proc Natl Acad Sci U S A, 100, pp.3983~3988 (2003)
5. Singh SK, "Identification of human brain tumour initiating cells", Nature, 432, pp.396~401 (2004)
6. Collins AT, "Prospective identification of tumorigenic prostate cancer stem cells", Cancer Res, 65, pp.10946~10951 (2005)
7. Li C, "Identification of pancreatic cancer stem cells", Cancer Res, 67, pp.1030~1037 (2007)
8. O'Brien CA, "A human colon cancer cell capable of initiating tumour growth in immunodeficient mice", Nature, 445, pp.106~110 (2007)
9. Zhang WC, "Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis", Cell, 148, pp.259~272 (2012)
10. Takaishi S, "Identification of gastric cancer stem cells using the cell surface marker CD44", Stem Cells, 27, pp.1006~1020 (2009)
11. Curley MD, "CD133 expression defines a tumor initiating cell population in primary human ovarian cancer", Stem Cells, 27, pp.2875~2883 (2009)
12. Terris B, "EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma", J Hepatol, 52, pp.280~281 (2010)
13. Boiko AD, "Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271", Nature, 466, pp.133~137 (2010)
14. Bach P, "Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus", Cancer Res, 73, pp.865~874 (2013)
15. Kaiser J, "The cancer stem cell gamble", Science, 347, pp.226~229 (2015)
16. Waldron NN, "A bispecific EpCAM", CD133-targeted toxin is effective against carcinoma, 2014, pp.9, 239~249
17. Schmohl JU, "CD133, Selectively Targeting the Root of Cancer", Toxins (Basel), 8, pp.165~ (2016)
18. Zhou BB, "Tumour-initiating cells: challenges and opportunities for anticancer drug discovery", Nat Rev Drug Discov, 8, pp.806~823 (2009)
19. Xia P, "Surface markers of cancer stem cells in solid tumors", Curr Stem Cell Res Ther, 9, pp.102~111 (2014)
20. Islam F, "Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment", Exp Cell Res, 335, pp.135~147 (2015)
21. Zhao W, "Embryonic stem cell markers", Molecules, 17, pp.6196~6236 (2012)
22. Thomson JA, "Embryonic stem cell lines derived from human blastocysts", Science, 282, pp.1145~1147 (1998)
23. Kuroda Y, "Unique multipotent cells in adult human mesenchymal cell populations", Proc Natl Acad Sci U S A, 107, pp.8639~8643 (2010)
24. Gang EJ, "SSEA-4 identifies mesenchymal stem cells from bone marrow", Blood, 109, pp.1743~1751 (2007)
25. Sandstedt J, "SSEA-4+ CD34- cells in the adult human heart show the molecular characteristics of a novel cardiomyocyte progenitor population", Cells Tissues Organs, 199, pp.103~116 (2014)
26. Chang WW, "Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis", Proc Natl Acad Sci U S A, 105, pp.11667~11672 (2008)
27. Schopperle WM, "The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma", Stem Cells, 25, pp.723~730 (2007)
28. Corominas-Faja B, "Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-　 like cellular states harboring transcriptional activation of the mTOR pathway", Cell Cycle, 12, pp.3109~3124 (2013)
29. Rajasekhar VK, "Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling", Nat Commun, 2, pp.162~ (2011)
30. Mao XG, "Brain Tumor Stem-Like Cells Identified by Neural Stem Cell Marker CD15", Transl Oncol, 2, pp.247~257 (2009)
31. Liebert M, "Detection of SSEA-1 on human renal tumors", Cancer, 59, pp.1404~1408 (1987)
32. Miyake M, "Stage-specific expression of SSEA-1-related antigens in the developing lung of human embryos and its relation to the distribution of these antigens in lung cancers", Cancer Res, 48, pp.7150~7158 (1988)
33. Grosse-Gehling P, "CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges", J Pathol, 229, pp.355~378 (2013)
34. Irollo E, "CD133: to be or not to be, is this the real question?", Am J Transl Res, 5, pp.563~581 (2013)
35. Yin AH, "AC133, a novel marker for human hematopoietic stem and progenitor cells", Blood, 90, pp.5002~5012 (1997)
36. Sundberg M, "CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells", Stem Cell Res, 2, pp.113~124 (2009)
37. Uchida N, "Direct isolation of human central nervous system stem cells", Proc Natl Acad Sci U S A, 97, pp.14720~14725 (2000)
38. Kemper K, "The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation", Cancer Res, 70, pp.719~729 (2010)
39. Dennis JE, "Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration", Stem Cells, 25, pp.2575~2582 (2007)
40. International Stem Cell I, "Characterization of human embryonic stem cell lines by the International Stem Cell Initiative", Nat Biotechnol, 25, pp.803~816 (2007)
41. Buishand FO, "Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas", Stem Cells Dev, 25, pp.826~835 (2016)
42. He J, "CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays", Mol Cell Proteomics, 11, pp.M111 01074~ (2012)
43. Yang ZF, "Significance of CD90+ cancer stem cells in human liver cancer", Cancer Cell, 13, pp.153~166 (2008)
44. Ng VY, "Characterization of epithelial cell adhesion molecule as a surface marker on undifferentiated human embryonic stem cells", Stem Cells, 28, pp.29~35 (2010)
45. in cancer: a short review, "Cancer Treat Rev", 2012, 68~75
46. Yamashita T, "EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem", progenitor cell features, 2009, pp.136, 1012~1024
47. Bianco C, "Role of Cripto-1 in stem cell maintenance and malignant progression", Am J Pathol, 177, pp.532~540 (2010)
48. Bianco C, "Targeting the embryonic gene Cripto-1 in cancer and beyond", Expert Opin Ther Pat, 20, pp.1739~1749 (2010)
49. Choo AB, "Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1", Stem Cells, 26, pp.1454~1463 (2008)
50. Kelley TW, "Podocalyxin : a marker of blasts in acute leukemia", Am J Clin Pathol, 124, pp.134~142 (2005)
51. Koch LK, "Stem cell marker expression in small cell lung carcinoma and developing lung tissue", Hum Pathol, 39, pp.1597~1605 (2008)
52. Padmanabhan R, "Lost in Translation: Regulation of ABCG2 Expression in Human Embryonic Stem Cells", J Stem Cell Res Ther, 4, pp.24230~ (2014)
53. Apati A, "High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells", Biochim Biophys Acta, 1778, pp.2700~2709 (2008)
54. Sarkadi B, "Evaluation of ABCG2 expression in human embryonic stem cells: crossing the same river twice?", Stem Cells, 28, pp.174~176 (2010)
55. Ho MM, "Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells", Cancer Res, 67, pp.4827~4833 (2007)
56. Kristiansen G, "Tumour biological aspects of CD24, a mucin-like adhesion molecule", J Mol Histol, 35, pp.255~262 (2004)
57. Zhang C, "Identification of CD44+CD24+ gastric cancer stem cells", J Cancer Res Clin Oncol, 137, pp.1679~1686 (2011)
58. Yu KR, "CD49f enhances multipotency and maintains stemness through the direct regulation of OCT4 and SOX2", Stem Cells, 30, pp.876~887 (2012)
59. Notta F, "Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment", Science, 333, pp.218~221 (2011)
60. Lathia JD, "Integrin alpha 6 regulates glioblastoma stem cells", Cell Stem Cell, 6, pp.421~432 (2010)
61. Yen WC, "Targeting notch signaling with a notch2", notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency, 2015, pp.21, 2084~2095
62. Fox V, "Cell-cell signaling through NOTCH regulates human embryonic stem cell proliferation", Stem Cells, 26, pp.715~723 (2008)
63. Imayoshi I, "Essential Roles of Notch Signaling in Maintenance of Neural Stem Cells in Developing and Adult Brains", J Neurosci, 30, pp.3489~3498 (2010)
64. Nodomi S, "CD146 is a novel marker for highly tumorigenic cells and a potential therapeutic target in malignant rhabdoid tumor", Oncogene, 35, pp.5317~5327 (2016)
65. Wei Q, "Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma", Oncotarget, 6, pp.40283~40294 (2015)
66. Galy A, "Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset", Immunity, 3, pp.459~473 (1995)
67. Mariotti E, "Comparative characteristics of mesenchymal stem cells from human bone marrow and placenta: CD10, CD49d, and CD56 make a difference", Stem Cells Dev, 17, pp.1039~1041 (2008)
68. Fukusumi T, "CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma", Br J Cancer, 111, pp.506~514 (2014)
69. Maguer-Satta V, "CD10: a tool to crack the role of stem cells in breast cancer", Proc Natl Acad Sci U S A, 108, pp.E1264~ (2011)
70. Carpenter MK, "Properties of four human embryonic stem cell lines maintained in a feeder-free culture system", Dev Dyn, 229, pp.243~258 (2004)
71. Miettinen M, "KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation", Appl Immunohistochem Mol Morphol, 13, pp.205~220 (2005)
72. Chen J, "Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures", BMC Cell Biol, 14, pp.7~ (2013)
73. Ou X, "Implications of DPP4 modification of proteins that regulate stem", progenitor and more mature cell types, 2013, pp.122, 161~169
74. Herrmann H, "Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia", Blood, 123, pp.3951~3962 (2014)
75. Pang R, "A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer", Cell Stem Cell, 6, pp.603~615 (2010)
76. Zhang L, "CXCR4 activation promotes differentiation of human embryonic stem cells to neural stem cells", Neuroscience, 337, pp.88~97 (2016)
77. Li M, "Chemokine receptor CXCR4 signaling modulates the growth factor-　 induced cell cycle of self-renewing and multipotent neural progenitor cells", Glia, 59, pp.108~118 (2011)
78. Mukherjee D, "The Role of chemokine receptor CXCR4 in breast cancer metastasis", Am J Cancer Res, 3, pp.46~57 (2013)
79. Dubrovska A, "CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling", Br J Cancer, 107, pp.43~52 (2012)
80. Civin CI, "Antigenic analysis of hemato poiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells", J Immunol, 133, pp.157~165 (1984)
81. Sutherland HJ, "Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers", Proc Natl Acad Sci U S A, 87, pp.3584~3588 (1990)
82. Schober M, "Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-beta and integrin", focal adhesion kinase(FAK)signaling, 2011, pp.108, 10544~10549
83. Buhring HJ, "Novel markers for the prospective isolation of human MSC", Ann NY Acad Sci, 1106, pp.262~271 (2007)
84. Quintana E, "Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized", Cancer Cell, 18, pp.510~523 (2010)
85. Bhagwat SV, "CD13", APN is activated by angiogenic signals and is essential for capillary tube formation, 2001, pp.97, 652~659
86. Rahman MM, "CD13 promotes mesenchymal stem cell-mediated regeneration of ischemic muscle", Front Physiol, 4, pp.492~ (2014)
87. Haraguchi N, "CD13 is a therapeutic target in human liver cancer stem cells", J Clin Invest, 120, pp.3326~3339 (2010)
88. Salcido CD, "Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer", Br J Cancer, 102, pp.1636~1644 (2010)
89. Shimojima M, "CD56 expression in feline lymphoid cells", J Vet Med Sci, 65, pp.769~773 (2003)
90. Altomonte M, "Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma", Br J Cancer, 74, pp.1586~1591 (1996)
91. Maleki M, "Comparison of mesenchymal stem cell markers in multiple human adult stem cells", Int J Stem Cells, 7, pp.118~126 (2014)
92. Saroufim A, "Tumoral CD105 is a novel independent prognostic marker for prognosis in clear-cell renal cell carcinoma", Br J Cancer, 110, pp.1778~1784 (2014)
93. Forster R, "Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells", Stem Cell Rep, 2, pp.838~852 (2014)
94. Barker N, "Identification of stem cells in small intestine and colon by marker gene Lgr5", Nature, 449, pp.1003~1007 (2007)
95. Barker N, "Lgr proteins in epithelial stem cell biology", Development, 140, pp.2484~2494 (2013)
96. Barker N, "Crypt stem cells as the cells-of-origin of intestinal cancer", Nature, 457, pp.608~611 (2009)
97. Kemper K, "Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells", Stem Cells, 30, pp.2378~2386 (2012)
98. Hirsch D, "LGR5 positivity defines stem-like cells in colorectal cancer", Carcinogenesis, 35, pp.849~858 (2014)
99. Ward AC, "The role of the granulocyte colony-stimulating factor receptor(G-CSF-R)in disease", Front Biosci, 12, pp.608~618 (2007)
100. Zage PE, "CD114: A New Member of the Neural Crest-Derived Cancer Stem Cell Marker Family", J Cell Biochem, 118, pp.221~231 (2017)
101. Hsu DM, "G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic", Cancer Res, 73, pp.4134~4146 (2013)
102. Tohma S, "Expression and distribution of CD11a", CD18 and CD54 during human T cell-B cell interactions, 1992, pp.52, 97~103
103. Amaral AT, "Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications", PLoS One, 9, pp.e85814~ (2014)
104. Chen T, "Identification and expansion of cancer stem cells in tumor tissues and peripheral blood derived from gastric adenocarcinoma patients", Cell Res, 22, pp.248~258 (2012)
105. Wilson S, "The CXCR1 and CXCR2 receptors form constitutive homoand heterodimers selectively and with equal apparent affinities", J Biol Chem, 280, pp.28663~28674 (2005)
106. Ringe J, "Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2", J Cell Biochem, 101, pp.135~146 (2007)
107. Singh JK, "Targeting CXCR1", 2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms, 2013, pp.19, 643~656
108. Chen L, "The IL-8", CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases, 2014, pp.4, 5911~
109. Kikushige Y, "TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells", Cell Stem Cell, 7, pp.708~717 (2010)
110. Ikeda J, "Prognostic significance of CD55 expression in breast cancer", Clin Cancer Res, 14, pp.4780~4786 (2008)
111. Pellegrinet L, "Dll1-and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells", Gastroenterology, 140, pp.1230~1240 (2011)
112. Hoey T, "DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency", Cell Stem Cell, 5, pp.168~177 (2009)
113. Fischer M, "Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations", Cancer Res, 71, pp.1520~1525 (2011)
114. O'Keefe TL, "Mice carrying a CD20 gene disruption", Immunogenetics, 48, pp.125~132 (1998)
115. Smith MR, "Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance", Oncogene, 22, pp.7359~7368 (2003)
116. Fang D, "A tumorigenic subpopulation with stem cell properties in melanomas", Cancer Res, 65, pp.9328~9337 (2005)
117. Wang PL, "Identification and molecular cloning of tactile. A novel human T cell activation antigen that is a member of the Ig gene superfamily", J Immunol, 148, pp.2600~2608 (1992)
118. Martinet L, "Balancing natural killer cell activation through paired receptors", Nat Rev Immunol, 15, pp.243~254 (2015)
119. Garg S, "Investigating cell surface markers on normal hematopoietic stem cells in three different niche conditions", Int J Stem Cells, 6, pp.129~133 (2013)
120. Hosen N, "CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia", Proc Natl Acad Sci U S A, 104, pp.11008~11013 (2007)
121. Goodfellow PJ, "Assignment of the gene encoding the beta-subunit of the human fibronectin receptor (beta-FNR) to chromosome 10p11.2", Ann Hum Genet, 53, pp.15~22 (1989)
122. Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)
123. Vassilopoulos A, "A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancer", Oncogene, 33, pp.5477~5482 (2014)
124. Zoller M, "Tetraspanins : push and pull in suppressing and promoting metastasis", Nat Rev Cancer, 9, pp.40~55 (2009)
125. Kim YJ, "Role of CD9 in proliferation and proangiogenic action of human adipose-derived mesenchymal stem cells", Pflugers Arch, 455, pp.283~296 (2007)
126. Yamazaki H, "Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia", Biochem Biophys Res Commun, 409, pp.14~21 (2011)
127. Zannettino AC, "Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo", J Cell Physiol, 214, pp.413~421 (2008)
128. Wang F, "Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay", Gastroenterology, 145, pp.383~395 (2013)
129. Levin TG, "Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract", Gastroenterology, 139, pp.2072~2082 (2010)
130. Tachezy M, "Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?", Stem Cells, 32, pp.1429~1436 (2014)
131. Thapa R, "The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer", Stem Cells Int, 2016, pp.2087204~ (2016)
132. Lapidot T, "How do stem cells find their way home?", Blood, 106, pp.1901~1910 (2005)
133. Zuk PA, "Human adipose tissue is a source of multipotent stem cells", Mol Biol Cell, 13, pp.4279~4295 (2002)
134. Zoller M, "CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?", Nat Rev Cancer, 11, pp.254~267 (2011)
135. Jaggupilli A, "Significance of CD44 and CD24 as cancer stem cell", Clin Dev Immunol, pp.708036~ (2012)
136. Nagano O, "Redox regulation in stem-like cancer cells by CD44 variant isoforms", Oncogene, 32, pp.5191~5198 (2013)
137. Hirata K, "CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence", Br J Cancer, 109, pp.379~386 (2013)
138. Yoshikawa M, "xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma", Cancer Res, 73, pp.1855~1866 (2013)
139. Ishimoto T, "CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-)and thereby promotes tumor growth", Cancer Cell, 19, pp.387~400 (2011)
140. Lau WM, "CD44v8-10 is a cancer-specific marker for gastric cancer stem cells", Cancer Res, 74, pp.2630~2641 (2014)
141. Ksander BR, "ABCB5 is a limbal stem cell gene required for corneal development and repair", Nature, 511, pp.353~357 (2014)
142. Schatton T, "Identification of cells initiating human melanomas", Nature, 451, pp.3445~349 (2008)
143. Miyauchi J, "The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture", Blood, 70, pp.657~663 (1987)
144. Sadras T, "Interleukin-3-　 mediated regulation of beta-catenin in myeloid transformation and acute myeloid leukemia", J Leukoc Biol, 96, pp.83~91 (2014)
145. Brewer BG, "Embryonic vaccines against cancer: an early history", Exp Mol Pathol, 86, pp.192~197 (2009)
146. Sell S, "On the stem cell origin of cancer", Am J Pathol, 176, pp.2584~2494 (2010)
147. Stonehill EH, "Retrogenetic expression: the reappearance of embryonal antigens in cancer cells", Nature, 228, pp.370~372 (1970)
148. Klavins JV, "Human carcinoma antigens cross reacting with anti-embryonic antibodies", Nat New Biol, 234, pp.153~154 (1971)
149. Bendich A, "Protection of adult mice against tumor challenge by immunization with irradiated adult skin or embryo cells", J Immunol, 111, pp.284~285 (1973)
150. Adinolfi M, "Cancer, oncogenes and oncofetal antigens", Q J Med, 54, pp.193~204 (1985)
151. Li Y, "Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical responses against colon cancer", Stem Cells, 27, pp.3103~3111 (2009)
152. Dong W, "Administration of embryonic stem cells generates effective antitumor immunity in mice with minor and heavy tumor load", Cancer Immunol Immunother, 59, pp.1697~1705 (2010)
153. Yaddanapudi K, "Vaccination with embryonic stem cells protects against lung cancer: is a broad-spectrum prophylactic vaccine against cancer possible?", PLoS One, 7, pp.e42289~ (2012)
154. Kim J, "A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs", Cell, 143, pp.313~324 (2010)
155. Ben-Porath I, "An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors", Nat Genet, 40, pp.499~507 (2008)
156. Narva E, "High-　 resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity", Nat Biotechnol, 28, pp.371~377 (2010)
157. Lee AS, "Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies", Nat Med, 19, pp.998~1004 (2013)
158. Dvorak P, "Fibroblast growth factor signaling in embryonic and cancer stem cells", FEBS Lett, 580, pp.2869~2874 (2006)
159. Clarke MF, "Stem cells and cancer: two faces of eve", Cell, 124, pp.1111~1115 (2006)
160. Choi HS, "Development of a decoy immunization strategy to identify cell-surface molecules expressed on undifferentiated human embryonic stem cells", Cell Tissue Res, 333, pp.197~206 (2008)
161. Choi HS, "Identification and characterization of adenovirus early region 1B-associated protein 5 as a surface marker on undifferentiated human embryonic stem cells", Stem Cells Dev, 20, pp.609~620 (2011)
162. Kim WT, "B-cell receptor-associated protein 31 regulates human embryonic stem cell adhesion, stemness, and survival via control of epithelial cell adhesion molecule", Stem Cells, 32, pp.2626~2641 (2014)
163. Medof ME, "Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement", Proc Natl Acad Sci U S A, 84, pp.2007~2011 (1987)
164. Stashenko P, "Characterization of a human B lymphocyte-　 specific antigen", J Immunol, 125, pp.1678~1685 (1980)
165. Reff ME, "Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20", Blood, 83, pp.435~445 (1994)
166. Gramatzki M, "Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia", Exp Hematol, 26, pp.1209~1214 (1998)

관련 논문AI추천